Joseph Antin, MD, Hematology, Boston, MA, Brigham and Women's Hospital

JosephHarryAntinMD

Hematology Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Antin is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Antin's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFELLOWSHIP
  • Brigham and Women's Hospital
    Brigham and Women's HospitalRESIDENCY
  • Weill Cornell Medical College of Cornell University
    Weill Cornell Medical College of Cornell UniversityMEDICAL_SCHOOL

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Development of HHV-6-Specific Immunity after Cord Blood Transplantation in Adults Depends on Reconstitution of Thymopoiesis and Regeneration of CD4+ T Cells
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/8/2019
  • Graft Failure after Haploidentical Hematopoietic Stem Cell Transplantation
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase 1 Dose-Escalation Study of Adding Venetoclax to a Reduced Intensity Conditioning (RIC) Regimen Prior to Allogeneic Hematopoietic Cell Transplantation for Patie...
    Joseph H. Antin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Grant Support

  • A Randomized Trial Of Tac/Mtx/Bortezomib VS Tac/Mtxplacebo In Allogeneic HSCTNational Heart, Lung, And Blood Institute2011
  • Novel Approaches To Graft-Versus-Host Disease PreventionNational Cancer Institute2009–2011
  • Mechanisms Of GVHDNational Cancer Institute2009–2011
  • Administrative CoreNational Cancer Institute2009–2011
  • Random Trial Of CD8 T-Cell Depletion In PBSC TransplantationNational Heart, Lung, And Blood Institute2006–2010
  • Novel Approaches To Ghvd PreventionNational Heart, Lung, And Blood Institute2007
  • Mechanisms Of GVHDNational Heart, Lung, And Blood Institute2003–2007
  • Randomized Trial Of CD8 T-Cell Depletion In PBSC Transp*National Heart, Lung, And Blood Institute2001–2005
  • Use Of Unrelated Donors For Bone Marrow TransplantationNational Center For Research Resources1997–1999
  • Phlebotomy For Research Studies After Marrow TransplantationNational Center For Research Resources1997–1999
  • Core--Clinical Bone Marrow Transplant ProgramNational Cancer Institute1997
  • Novel Therapy For Chronic Myelogenous LeukemiaNational Cancer Institute1993–1996

Professional Memberships

Hospital Affiliations